Search

Gates MRI’s Exploratory Biomarker Leader, Nicole Frahm, and Clinical Development Leader, David Holtzman, contributed to the important review of new TB treatment monitoring biomarkers with colleagues from UNITE4TB and FIND — the global alliance for diagnostics.

Caused by Plasmodium parasites, spread through the bite of infected Anopheles mosquitoes

Research Priorities Gates MRI focuses on programs aimed at reducing the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). All Research Priorities Malaria Caused by Plasmodium parasites, spread through the bite of infected Anopheles mosquitoes…

Gates MRI’s CEO Emilio Emini gave an in-depth interview to the Progress, Potential, and Possibilities podcast on immunology, vaccinology, and his career in public health. He also provided an overview of Gates MRI’s research priorities and discussed a call-to-action for preparedness ahead of the next pandemic.

As chief operating officer at the Bill & Melinda Gates Medical Research Institute, Debra Weiss, RN, MSN, provides strategic and operational support to achieve business objectives in compliance with Gates MRI and industry standards for data integrity, safety, and quality. She has overseen operations since Gates MRI  was founded in…

Gates MRI’s Head of Therapeutics Development, Charles Wells, wrote a post for Medicines Patent Pool outlining public health challenges stemming from tuberculosis. He also highlighted how partnerships can play a key role in helping to contribute to ending the TB epidemic by 2030. 

As head of corporate strategy at the Bill & Melinda Gates Medical Research Institute, Claire M. Wagner, M.D., M.B.A., drives forward Gates MRI’s mission and vision, advising the CEO on enterprise-level strategy across a range of vantage points. Prior to her role as head of corporate strategy, Claire served as…